Nu Skin Enterprises, Inc.

  • Market Cap: Micro Cap
  • Industry: FMCG
  • ISIN: US67018T1051
USD
9.81
-0.17 (-1.7%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Nu Skin Enterprises, Inc. stock-summary
stock-summary
Nu Skin Enterprises, Inc.
FMCG
Nu Skin Enterprises, Inc. is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system. The Pharmanex product line includes ageLOC Youth nutritional supplement, ageLOC TR90 weight management and body shaping system, and LifePak nutritional supplements. The Company has operations in various geographic regions, including Greater China, North Asia, Americas, South Asia/Pacific, and Europe, the Middle East and Africa (EMEA). It is focused on offering ageLOC Youth nutritional supplement and ageLOC Me personalized skin care system. The Company also offers household products and technology services.
Company Coordinates stock-summary
Company Details
75 W Center St , PROVO UT : 84601-4432
stock-summary
Tel: 1 801 3451000
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 58 Schemes (42.6%)

Foreign Institutions

Held by 107 Foreign Institutions (8.97%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Steven Lund
Executive Chairman of the Board
Mr. Ritch Wood
Chief Executive Officer, Director
Mr. Daniel Campbell
Lead Independent Director
Mr. Andrew Lipman
Independent Director
Ms. Laura Nathanson
Independent Director
Mr. Thomas Pisano
Independent Director
Mr. Zheqing Shen
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
386 Million
(Quarterly Results - Jun 2025)
Net Profit:
21 Million
stock-summary
Industry

FMCG

stock-summary
Market cap

USD 1,036 Million (Micro Cap)

stock-summary
P/E

4.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.15%

stock-summary
Debt Equity

-0.02

stock-summary
Return on Equity

24.02%

stock-summary
Price to Book

1.31